Biosimilars poised to make biologics more routine

The biosimilar age for rheumatology has arrived, and experts expect wider use of previously expensive biologic drugs as biosimilar competition drives prices down and makes biologics more...

Field of Interest: Rheumatology
Type: News Item

Drug combos for psoriatic arthritis upped shingles risk

Combining tumor necrosis factor-alpha inhibitors with conventional disease-modifying antirheumatic drugs more than doubled the risk of shingles in patients with psoriatic arthritis, according to a...

Field of Interest: Rheumatology
Type: News Item

Drug combos for psoriatic arthritis upped shingles risk

Combining tumor necrosis factor-alpha inhibitors with conventional disease-modifying antirheumatic drugs more than doubled the risk of shingles in patients with psoriatic arthritis, according to a...

Field of Interest: Dermatology
Type: News Item

Combination therapy best in RA regardless of prognosis

Rheumatoid arthritis patients with differing prognoses achieved similar improvements in clinical outcomes and functional improvements with initial combination therapy but fared differently when given...

Field of Interest: Rheumatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.